Prenatal diagnosis of mucolipidosis type II on first‐trimester amniotic fluid

Livia Poenaru, Christine Mezard, Said Akli, Jean‐François ‐F Oury, Yves Dumez, Joëlle Boue

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

We investigated the possibility of prenatal diagnosis of mucolipidosis type II (ML II) by lysosomal enzyme determination on amniotic fluid obtained at 11 weeks of gestation in three pregnancies at risk. Diagnosis of ML II was made in one case on the basis of increased levels of five lysosomal enzymes tested. The diagnosis was confirmed on cultured chorionic cells, their cultured medium, 17–week amniotic fluid, and fetal plasma obtained for confirmation prior to the termination of pregnancy.

Original languageEnglish (US)
Pages (from-to)231-235
Number of pages5
JournalPrenatal diagnosis
Volume10
Issue number4
DOIs
StatePublished - Apr 1990

Keywords

  • Amniotic fluid lysosomal enzymes
  • I‐cell disease
  • Mucolipidosis II

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Genetics(clinical)

Fingerprint

Dive into the research topics of 'Prenatal diagnosis of mucolipidosis type II on first‐trimester amniotic fluid'. Together they form a unique fingerprint.

Cite this